Scientists fear disruptive Trump policies could lead to a brain drain and undermine the nation's leadership in biomedicine ...
28m
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...
Hosted on MSN14m
LLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising questions about their safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback